Danaher Corporation $DHR Shares Sold by King Luther Capital Management Corp

King Luther Capital Management Corp decreased its holdings in Danaher Corporation (NYSE:DHR) by 1.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,368,617 shares of the conglomerate’s stock after selling 18,194 shares during the quarter. Danaher makes up 1.3% of King Luther Capital Management Corp’s portfolio, making the stock its 18th biggest position. King Luther Capital Management Corp owned 0.19% of Danaher worth $313,304,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the stock. Elevated Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter worth about $26,000. JPL Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter worth approximately $25,000. WFA of San Diego LLC bought a new stake in Danaher in the second quarter valued at $26,000. ANTIPODES PARTNERS Ltd acquired a new position in Danaher during the 3rd quarter valued at about $27,000. Finally, Capco Asset Management LLC acquired a new position in shares of Danaher during the fourth quarter worth approximately $34,000. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently weighed in on DHR. Barclays reduced their price objective on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Evercore increased their price objective on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research report on Tuesday, April 21st. Jefferies Financial Group reiterated a “buy” rating and issued a $245.00 target price on shares of Danaher in a report on Tuesday, April 21st. Guggenheim decreased their target price on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Finally, TD Cowen decreased their price target on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Twenty analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average target price of $238.24.

Danaher Stock Up 0.6%

Shares of Danaher stock opened at $172.96 on Wednesday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The stock has a 50 day moving average price of $182.94 and a two-hundred day moving average price of $208.13. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $122.42 billion, a P/E ratio of 33.45, a PEG ratio of 2.30 and a beta of 0.81.

Danaher (NYSE:DHR) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.88 EPS. Equities analysts expect that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.